Gaxos 2025 Q3 Earnings Net Loss Widens Despite EPS Improvement

Generated by AI AgentDaily EarningsReviewed byRodder Shi
Saturday, Nov 15, 2025 5:39 am ET1min read
Aime RobotAime Summary

-

(GXAI) reported 18,327.2% revenue surge to $498,271 in Q3 2025, driven by RNK Health, but net loss widened 32% to $1.14M.

- Despite 77% EPS improvement to -$0.14, shares fell 33.67% month-to-date, contrasting historical 28.32% post-earnings returns.

- The company will showcase AI health solutions at WAWTech 2025 in Warsaw, aiming to strengthen European tech partnerships amid volatile market reactions.

Gaxos (GXAI) reported its fiscal 2025 Q3 earnings on Nov 14, 2025, revealing a 18,327.2% revenue surge but a deteriorating net loss. While the company narrowed its per-share loss, the overall net loss expanded by 32%, highlighting mixed performance.

Revenue

Gaxos’s total revenue skyrocketed to $498,271 in 2025 Q3, a 18,327.2% increase from $2,704 in the prior-year period. The surge was driven by RNK Health, which contributed $441,228, while subscription services added $57,042. In-app games accounted for a nominal $1, underscoring the dominance of health-related offerings in the revenue mix.

Earnings/Net Income

The company reduced its per-share loss to $0.14 in 2025 Q3 from $0.61 in 2024 Q3, a 77.0% improvement. However, the net loss worsened to $1.14 million, a 32.0% increase from $864,410 in the prior year. This divergence reflects higher operational costs or expenses offsetting EPS gains.

Price Action

Gaxos’s stock price fell 33.67% month-to-date, despite a historically positive 28.32% average return for investors buying shares on earnings dates and holding for 30 days over the past three years. The stock’s recent underperformance contrasts with its long-term post-earnings momentum.

Post-Earnings Price Action Review

The strategy of purchasing

shares on earnings release dates and holding for 30 days historically delivered a 28.32% return over the past three years. While 2023 and 2024 showed consistent gains (20.56% and 15.23%, respectively), 2025 was mixed: a 32.45% spike followed the first earnings release, but returns tapered to 8.54% by year-end, indicating volatility in market response.

CEO Commentary

No CEO commentary was available due to missing transcript data.

Guidance

No forward-looking guidance was provided in the earnings report.

Additional News

Gaxos will participate in the WAWTech Conference in Warsaw, Poland, from Dec 16–17, 2025, to showcase its AI applications in health and gaming. CEO Vadim Mats emphasized the event’s role in fostering European tech partnerships. The conference, drawing over 5,000 IT professionals, features speakers from Google, Netflix, and Asana. Gaxos aims to position itself as a leader in AI-driven health and wellness solutions.

Comments



Add a public comment...
No comments

No comments yet